Tag Archives: Edwards Lifesciences

Edwards Lifesciences (EW) Received its Third Buy in a Row

After Wells Fargo and Cowen & Co. gave Edwards Lifesciences (NYSE: EW) a Buy rating last month, the company received another Buy, this time from Raymond James. Analyst Jayson Bedford maintained a Buy rating on Edwards Lifesciences today and set

Edwards Lifesciences (EW): New Buy Recommendation for This Healthcare Giant

In a report released today, Raj Denhoy from Jefferies maintained a Buy rating on Edwards Lifesciences (EW – Research Report), with a price target of $180. The company’s shares closed on Tuesday at $157.35. According to TipRanks.com, Denhoy is a

The VP, Corp. Contr of Edwards Lifesciences is Exercising Options

Today it was reported that the VP, Corp. Contr of Edwards Lifesciences (EW – Research Report), Robert Sellers, exercised options to sell 7,859 EW shares at $42.72 a share, for a total transaction value of $1.2M. Following Robert Sellers’ last

Citigroup Maintains Their Sell Rating on Edwards Lifesciences (EW)

In a report released today, Amit Hazan from Citigroup maintained a Sell rating on Edwards Lifesciences (NYSE: EW), with a price target of $118. The company’s shares opened today at $142.57. According to TipRanks.com, Hazan is a 4-star analyst with

Edwards Lifesciences (EW) Gets a Hold Rating from Northland Securities

Northland Securities analyst Suraj Kalia maintained a Hold rating on Edwards Lifesciences (NYSE: EW) today and set a price target of $120. The company’s shares opened today at $147.02. Kalia noted: “We highlight our concerns underneath & are tweaking our

Northland Securities Maintains Their Hold Rating on Edwards Lifesciences (EW)

In a report released today, Suraj Kalia from Northland Securities maintained a Hold rating on Edwards Lifesciences (NYSE: EW), with a price target of $120. The company’s shares opened today at $140. Kalia wrote: “We analyze data on MitraClip +